![‘Culture is critical to performance’: Aligning values and strategy with Paul Ingram](/content/dam/images/stock/TBP-episode-with-Paul-Ingram-carousel.jpg)
FEATURED EPISODE
‘Culture is critical to performance’: Aligning values and strategy with Paul Ingram
What’s the role of culture in an organization and how can it play a pivotal role in shaping performance or even helping businesses transform? On this episode of “Transforming Biopharma,” Maria Whitman sits down with Paul Ingram, professor at Columbia University, to explore the critical role of culture and organizational dynamics in driving successful transformation.
![tbp episod with mike tushman carousel](/content/dam/images/stock/t-b-p-episode-with-mike-tushman-carousel.jpg)
FEATURED EPISODE
Beyond process improvement: Why organizational architecture matters with Mike Tushman
Maria Whitman interviews Mike Tushman, professor at Harvard Business School, about the importance of organizational architecture during times of transformation. He describes how companies that successfully transform create an organizational architecture that allows both “exploitation” of existing successful strategies and “exploration” of what they might build for the future. He also discusses the role of leaders in driving transformation and the potential of generative AI.
![Susa-Monacelli-Episode-TBP-Podcast-insight](/content/dam/images/stock/Oya-Gilbert-episode-TBP-podcast-carousel-series.png)
Featured episode
Navigating the system, meeting patients where they are with Oya Gilbert
How can healthcare and biopharma meet patients where they are? Maria Whitman interviews Oya Gilbert, a podcaster and patient advocate, about his journey as a multiple myeloma patient. They also talk about Oya’s work with the Health, Hope and Hip-Hop Foundation, which aims to use hip-hop culture to promote health literacy in underserved communities.
Featured episode
From data collection to data connection: Reinventing pharma’s commercial model
How can pharma use AI and other technology to deliver a better customer experience? Maria Whitman and a panel of ZS experts discuss pharma’s next-generation commercial model.
![572116-Bills-episode-TBP-podcast-carosael-V1-R4](/content/dam/images/stock/572116-Bills-episode-TBP-podcast-carosael-V1-R4.jpg)
Featured episode
Resetting how we think about obesity: A patient’s point of view
Bill Coyle, ZS’s global head of biopharma, and Mandi White-Ajmani, Ph.D., clinical psychologist, join Maria Whitman to talk about the underlying challenges obesity presents to society and healthcare even as new treatments emerge. Dr. White-Ajmani shares her weight loss journey and reflects on how it has affected her life.
![Picture of Arun Shastri and Maria Whitman](/content/dam/images/stock/Arun-Episode-TBP%20Podcast-collaterals-carousel.jpg)
Featured episode
Disruptors, influencers and the modern customer experience with Arun Shastri
- D
- A
- G
- B
- E
- C
Miniseries
- Future of Commercial Model
- Future of Health
- Precision Medicine
Pharma's commercial model of tomorrow starts today
Building connections to reimagine healthcare
How biopharma can mobilize to design, develop and deliver precision medicine
About the Host
Maria Whitman is ZS’s managing partner, global commercialization strategy and solutions. A longtime leader in life sciences, she is dedicated to advancing health. She advises on strategy for top pharmaceutical and biotech companies to drive performance and engagement in the ecosystem to improve patient outcomes.